MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. - Wikidata - awgldk - TriplyDB

MDR1 Ala893 polymorphism is associated with inflammatory bowel disease.

MDR1 Ala893 polymorphism is associated with inflammatory bowel disease.

http://www.wikidata.org/entity/Q33905302

about

Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics TNFSF15 is an ethnic-specific IBD gene Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci Association of the T allele of an intronic single nucleotide polymorphism in the colony stimulating factor 1 receptor with Crohn's disease: a case-control study Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature Pharmacogenetics in inflammatory bowel disease Genetic predictors of medically refractory ulcerative colitis Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.Multidrug resistance 1 gene polymorphisms may determine Crohn's disease behavior in patients from Rio de Janeiro.Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene Differential susceptibility of P-glycoprotein deficient mice to colitis induction by environmental insults.Keratin mutations and intestinal pathology.Novel genetic markers in inflammatory bowel disease.Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel disease.Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis.ABC multidrug transporters: structure, function and role in chemoresistance.MDR1 polymorphisms are associated with inflammatory bowel disease in a cohort of Croatian IBD patients.Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship.Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene.Inflammatory bowel disease gene hunting by linkage analysis: rationale, methodology, and present status of the field.Clinical implications of inflammatory bowel disease genetics on phenotype.Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.Integrative Network-based Analysis of Colonic Detoxification Gene Expression in Ulcerative Colitis According to Smoking Status.Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology Multidrug resistance (MDR1) gene in inflammatory bowel disease: a key player?Determination of Vitamin D Serum Levels and Status of the C3435T Polymorphism of Multidrug Resistance 1 Gene in Southeastern Iranian Patients with Ulcerative Colitis.Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?Mammalian gut immunity.Genetic variants and the risk of Crohn's disease: what does it mean for future disease management?ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research.Inflammatory bowel disease and the apical junctional complex.Genetics of inflammatory bowel disease: current status and future directions.Review article: interactions between genotype and response to therapy in inflammatory bowel diseases.Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis.Genetics of the innate immune response in inflammatory bowel disease.Modeling inflammatory bowel disease: the zebrafish as a way forward.Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation.

P2860

Q21131205-13D7EB51-BBC6-406A-9C00-6D2A959B15F4 Q24644834-2339FE99-637F-4852-AE21-2325A689441E Q24670061-0699E9B0-A76D-40DB-9056-48C78D9683FD Q24794971-0C3656B9-EABD-4271-86C9-CC85203574CF Q26851693-387EB5CC-CA01-4C0A-B62E-F1E69C579F7B Q26852514-B263D989-276E-42D9-A53D-2008D6FA26B6 Q28246002-04ADF041-1811-487F-BB35-5ACF1959F3C4 Q28943368-6BD9F7A5-1FFD-483C-9726-381B3706B2A9 Q33268368-A1879E20-4ED2-4284-8117-E8CF85447BF4 Q33574823-9A6719B4-5469-45FD-84DE-41FAD7DB4B31 Q33788351-6ABFC2E7-7443-4EB1-88E7-243615401E53 Q33921440-E46CC494-D0CD-4848-A478-0BE4D56F2576 Q33982454-D97B555D-5140-40AC-BC60-A72B5F913297 Q34233119-F0441C2B-CF74-49CF-9132-16B17393779F Q34396606-EDBBF92A-6875-4A5F-8F34-2D028602A30C Q34538009-F097A0C4-A644-4DA3-9F9F-D7C1267CCC20 Q34586418-89EDA0C2-D85D-419B-91F2-80C44DD4B0CF Q34640725-0CE3E669-3FAF-45E2-80CF-C55B6D15A798 Q34695874-0D9EDE3A-3567-47A7-8B23-99AB53D1F77E Q34899429-B54F71E2-9EC2-492C-9FE8-F76006F2C7AD Q34994901-6FB186F4-F732-4E92-8C5F-34746300975E Q35047787-55A5E986-DFB4-47DA-A5B8-D5F7510E2FB2 Q35854522-2F46DCC8-25FA-4EE7-BF18-E02ED86FACEB Q36021426-80F27242-EE36-4A2B-BCDB-A77E5BB58C25 Q36120816-9DE69A1E-BDE4-427C-B535-CD2D8AF491D6 Q36153030-A2057705-43C3-4A7D-AD04-57568636D361 Q36245600-FE1A7704-0461-43D7-A1CF-1F6CFBE35A63 Q36292830-243E65C8-459E-4C22-A0E4-F1F46AF4E1E2 Q36306906-5FA6EB53-8756-4CCF-835C-6F1751671348 Q36446276-EC0C0349-E376-4FC3-8D77-D6149D0FA8EB Q36468059-1FAA28A0-1902-44D2-98C4-B297AC35AA80 Q36548717-8557B597-E531-4CBB-BDCB-C57D64C8453F Q36592129-355B16D1-6B58-43D8-9A67-CB2318064399 Q36631468-17661DCC-14D1-47B5-A5A6-0C53D0012825 Q36635088-3FED4EBE-FC07-4526-9197-4F24ADB10119 Q36642796-9282DE87-0AE1-4B64-B8D6-4512C4F56924 Q36700662-9C3ADB65-D7CF-4378-8725-A38EBDFBE245 Q36700670-22F3E3FC-BC3C-4C3A-AA70-EABBA87F342F Q36748510-93A081D3-FDD0-47CE-AC35-782AAC0A8CBF Q36809889-E4D5CA4C-BEF5-4917-97D3-56C106762A29

P2860

MDR1 Ala893 polymorphism is associated with inflammatory bowel disease.

http://www.wikidata.org/entity/Q33905302

description

2003 nî lūn-bûn

@nan

2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

MDR1 Ala893 polymorphism is associated with inflammatory bowel disease.

@ast

MDR1 Ala893 polymorphism is associated with inflammatory bowel disease.

@en

type

label

MDR1 Ala893 polymorphism is associated with inflammatory bowel disease.

@ast

MDR1 Ala893 polymorphism is associated with inflammatory bowel disease.

@en

prefLabel

MDR1 Ala893 polymorphism is associated with inflammatory bowel disease.

@ast

MDR1 Ala893 polymorphism is associated with inflammatory bowel disease.

@en

P1433

Q33905302-CEEAB191-84A1-4F40-AB90-05F2B5468366

P1476

Q33905302-F45A4430-1890-4B66-89CC-EDF12E899CF8

P2093

Q33905302-06F612E4-9B71-41BA-8EE6-7019963EEDB0

Q33905302-1A1899BB-5763-406C-A593-E78534EE9890

Q33905302-25908EDB-2A33-4BD3-B014-FDFA9D7CE7DB

Q33905302-302B7424-B0AD-49EC-B536-A0EBA0B90E06

Q33905302-42B95249-AEFC-4D37-81B7-D622A82CEB2E

Q33905302-5BEC4C0B-57AD-447C-B8F0-64AD420343D0

Q33905302-5D82F653-5740-4510-AC53-AE1E46953FE8

Q33905302-63DA417E-7E4F-487A-81EF-42945CD2267F

Q33905302-A2D99570-30F4-4338-9C79-66F20584D7DE

Q33905302-AD01A880-A1B7-41CB-A4A5-5051F16E008C

P2860

Q33905302-02BF4AAF-60DF-4C77-8E1C-4371012E5834

Q33905302-0C3EA2D0-D1B3-474E-AC85-0E6CB3941D1D

Q33905302-0EBB295D-3260-473F-939C-2FAC4A33A373

Q33905302-105AE3D5-96A1-473A-B437-79EDCBA7E64D

Q33905302-18E45CDA-DEF1-457A-9A04-774D6EDE219C

Q33905302-1BFF7D8A-14B2-42C5-91CC-114C600DF4FA

Q33905302-2214897B-F606-4F86-B84E-2D8F9F6E910F

Q33905302-249E6A3B-6E98-4B08-86A7-E236F35CA564

Q33905302-2F58FD35-B91D-4CF9-85A6-4FDC4D1A806E

Q33905302-3ACFB8D5-AB3E-44CA-A775-FD15AA6DDC5C

P304

Q33905302-A7AD2244-A77B-4139-B02F-48915E6A7107

P31

Q33905302-96ACD3C9-E6B7-4FA0-BB9F-E2519CECDC69

P356

Q33905302-665B08A3-1692-4D95-AB88-475D24B0BF6A

P407

Q33905302-700930B8-078A-459D-94BE-5FEACF56F825

P433

Q33905302-ECA2F719-430C-49A9-B359-38C018882644

P478

Q33905302-A7329343-0AC6-45C5-AF53-4766B2277B31

P50

Q33905302-2469975D-DEE3-42BD-9FA9-32D2266854C8

Q33905302-36328D47-96E5-41C4-BFD9-B2A24A2860FE

P577

Q33905302-BDE4B520-F2A5-42E7-9A91-CD0BC20C5651

P5875

Q33905302-824A98CF-5E59-481D-A40F-50B8BD7B2218

P698

Q33905302-2DB9494E-649E-41A0-AEAD-09C6195C594D

P921

Q33905302-AA487F5A-DA79-441B-A0DA-D7BA44A19EB2

Q33905302-E4E37D5F-93AD-44FD-B70A-5B59671B22F0

P932

Q33905302-5FD50921-D699-4576-8B84-E9B92AF473C7

P356

P1433

American Journal of Human Genetics

P1476

MDR1 Ala893 polymorphism is associated with inflammatory bowel disease.

@en

P2093

Amir S Karban

http://www.w3.org/2001/XMLSchema#string

Carolien I M Panhuysen

http://www.w3.org/2001/XMLSchema#string

Deepthi M Reddy

http://www.w3.org/2001/XMLSchema#string

Denise K Bonen

http://www.w3.org/2001/XMLSchema#string

Eric Swanson

http://www.w3.org/2001/XMLSchema#string

Geoffrey Ravenhill

http://www.w3.org/2001/XMLSchema#string

Jean-Paul Achkar

http://www.w3.org/2001/XMLSchema#string

Judy H Cho

http://www.w3.org/2001/XMLSchema#string

Leilei Zhang

http://www.w3.org/2001/XMLSchema#string

Lisa W Datta

http://www.w3.org/2001/XMLSchema#string

P2860

Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking

Inflammatory Bowel Disease

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease

Mapping of a susceptibility locus for Crohn's disease on chromosome 16

Parametric and nonparametric linkage analysis: a unified multipoint approach

Protein kinase C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels

P304

1282-1292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/379927

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9014371

http://www.w3.org/2001/XMLSchema#string

P698

14610718

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

1180394

http://www.w3.org/2001/XMLSchema#string